Scarica l'app Stockscreener
0.4297
1.58%
0.0067
Dopo l'orario di chiusura:
.43
0.0003
+0.07%
Precedente Chiudi:
$0.423
Aprire:
$0.42
Volume 24 ore:
247.27K
Relative Volume:
0.36
Capitalizzazione di mercato:
$3.89M
Reddito:
-
Utile/perdita netta:
$-18.35M
Rapporto P/E:
-0.3704
EPS:
-1.16
Flusso di cassa netto:
$-19.20M
1 W Prestazione:
+5.58%
1M Prestazione:
-14.40%
6M Prestazione:
-71.92%
1 anno Prestazione:
-99.67%
Intervallo 1D:
$0.4005
$0.43
Intervallo di 1 settimana:
$0.3654
$0.43
Portata 52W:
$0.3654
$144.38
Theriva Biologics Inc Stock (TOVX) Company Profile
Nome
Theriva Biologics Inc
Settore
Industria
Telefono
301 417 4364
Indirizzo
9605 Medical Center Drive, Suite 270, Rockville
Confronta TOVX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TOVX
Theriva Biologics Inc
|
0.4297 | 3.83M | 0 | -18.35M | -19.20M | -1.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Theriva Biologics Inc Borsa (TOVX) Ultime notizie
Theriva Biologics: Q2 Earnings Snapshot - New Haven Register
Theriva Biologics Faces Financial Risks Amid Shifting Trade Policies and Tariffs - TipRanks
Will Theriva Biologics Inc. stock go up soonProfit Target Planning with Exit Confidence - Newser
Theriva Biologics Reports Promising Trial Results and Financials - TipRanks
Theriva™ Biologics Reports Second Quarter 2025 Operational Highlights and Financial Results - GlobeNewswire
Theriva Biologics reports Q2 2025 financials, $12.1mln cash, VCN-01 data positive. - AInvest
Breakthrough: Theriva's VCN-01 Drug Shows Survival Benefits in Phase 2b Pancreatic Cancer Trial - Stock Titan
Theriva Biologics Inc. stock daily chart insightsSmart Risk Entry Zone Technical Analysis - Newser
Why Theriva Biologics Inc. stock attracts strong analyst attentionMomentum Trading Guide with Safety Limits - Newser
How high can Theriva Biologics Inc. stock price go in 2025Alpha Trade Flow With Risk Calibration - Newser
Is Theriva Biologics Inc. forming a reversal patternReversal Signal Prediction Based on Volume - Newser
Will earnings trigger a reversal in Theriva Biologics Inc.Free Early Entry Picks Before News Breakout - Newser
What makes Theriva Biologics Inc. stock price move sharplyMachine Learning Stock Movement Detector - Newser
Is Theriva Biologics Inc. stock reversal real or fakeReal Trader Watchlist with Entry Targets - Newser
How Theriva Biologics Inc. stock performs during market volatilityEquity Signal Recap With Long-Term Summary - Newser
Detecting support and resistance levels for Theriva Biologics Inc.Chart Confirmation Setup with ROI Signals - Newser
How hedge fund analytics apply to Theriva Biologics Inc. stockSwing Entry Risk Mitigation with Chart Analysis - Newser
Analyzing net buyer seller activity in Theriva Biologics Inc.Consistent Profit Signals with AI Models - Newser
Can Theriva Biologics Inc. weather a recessionFree High Accuracy Stock Picks - sisaissue.com
Is Theriva Biologics Inc. stock ready for a breakout5-Year Price Trend Summary and Analysis - Newser
Signal strength of Theriva Biologics Inc. stock in tech scannersReliable Setup Screener with Low Risk - Newser
Is Theriva Biologics Inc. a candidate for recovery playPortfolio Allocation Strategy for Stability - Newser
Theriva Biologics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayWatchlist Generator With Real-Time Entry - Newser
How does Theriva Biologics Inc. compare to its industry peersDiscover top stock picks for aggressive growth - Jammu Links News
Is Theriva Biologics Inc. stock overvalued or undervaluedSpectacular growth rates - Jammu Links News
Theriva Biologics Inc. Stock Analysis and ForecastMassive profits - Jammu Links News
What are analysts’ price targets for Theriva Biologics Inc. in the next 12 monthsUnlock powerful trading strategies for gains - Jammu Links News
How volatile is Theriva Biologics Inc. stock compared to the marketFree Technical Analysis Support - Jammu Links News
What is Theriva Biologics Inc. company’s growth strategyAmplify your gains with low-risk picks - Jammu Links News
How strong is Theriva Biologics Inc. company’s balance sheetAccess daily stock market expert updates - Jammu Links News
Is it the right time to buy Theriva Biologics Inc. stockMaximize returns with effective portfolio management - Jammu Links News
Why is Theriva Biologics Inc. stock attracting strong analyst attentionUnlock the power of real-time market data - Jammu Links News
Predicting Theriva Biologics Inc. trend using moving averagesAlgorithmic Forecast for Swing Trading Picks - Newser
Real time alert setup for Theriva Biologics Inc. performanceFree Technical Entry Strategy for Beginners - Newser
Theriva Biologics Inc Azioni (TOVX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.91%
3.06%
Capitalizzazione:
|
Volume (24 ore):